WO2023247608 - SYSTEMS AND METHODS FOR REGIMEN ADHERENCE EVALUATION

National phase entry:
Publication Number WO/2023/247608
Publication Date 28.12.2023
International Application No. PCT/EP2023/066766
International Filing Date 21.06.2023
Title **
[English] SYSTEMS AND METHODS FOR REGIMEN ADHERENCE EVALUATION
[French] SYSTÈMES ET PROCÉDÉS D'ÉVALUATION D'ADHÉSION À UN TRAITEMENT
Applicants **
NOVO NORDISK A/S
Inventors
ARADÓTTIR, Tinna, Björk
RYDE, Thomas, Emil
CICCONE, Nicholas, William
JENSEN, Maria, Sejersen
BENGTSSON, Henrik
Priority Data
22180912.2   24.06.2022   EP
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1879
EPO Filing, Examination, Granting8141
Japan Filing, Examination, Granting2015
South Korea Filing, Examination, Granting1749
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 18,524

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] A diabetes management system adapted to determine adherence for a subject in treatment according to a basal insulin regimen, the system being adapted to receive regimen data, BG data and insulin injection data. If one or more insulin injections have not been received in accordance with the prescribed regimen and thus are missing, the system is adapted to calculate for each missing injection an expected dose response BG value. By comparing received BG data, corresponding to the missing insulin injections, it can be determined for a given confidence interval whether or not the subject has been in adherence with the basal insulin regimen.[French] L'invention concerne un système de gestion du diabète conçu pour déterminer l'adhésion d'un sujet à un traitement selon un traitement à l'insuline basale, le système étant conçu pour recevoir des données de traitement, des données de BG et des données d'injection d'insuline. Si une ou plusieurs injections d'insuline n'ont pas été reçues conformément au traitement prescrit et sont donc manquantes, le système est conçu pour calculer pour chaque injection manquante une valeur de BG de dose-réponse attendue. En comparant des données de BG reçues, correspondant aux injections d'insuline manquantes, il peut être déterminé pour un intervalle de confiance donné si le sujet a ou non respecté le traitement à l'insuline basale.

Rejoining the server...